Myocardial interstitial fibrosis in the era of precision medicine. Biomarker-based phenotyping for a personalized treatment

MLA

Ravassa, S., et al. Myocardial Interstitial Fibrosis in the Era of Precision Medicine. Biomarker-Based Phenotyping for a Personalized Treatment. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..a79de27bb4640289e1cada4c7a7e85f0&authtype=sso&custid=ns315887.

APA

Ravassa, S., Gonzalez, A., Bayes-Genis, A., Lupon, J., & Diez, J. (2020). Myocardial interstitial fibrosis in the era of precision medicine. Biomarker-based phenotyping for a personalized treatment.

Chicago

Ravassa, S, A Gonzalez, A Bayes-Genis, J Lupon, and J Diez. 2020. “Myocardial Interstitial Fibrosis in the Era of Precision Medicine. Biomarker-Based Phenotyping for a Personalized Treatment,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..a79de27bb4640289e1cada4c7a7e85f0&authtype=sso&custid=ns315887.